| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |